AU2017219871B2 - Compositions and methods for treating liver cancer - Google Patents

Compositions and methods for treating liver cancer Download PDF

Info

Publication number
AU2017219871B2
AU2017219871B2 AU2017219871A AU2017219871A AU2017219871B2 AU 2017219871 B2 AU2017219871 B2 AU 2017219871B2 AU 2017219871 A AU2017219871 A AU 2017219871A AU 2017219871 A AU2017219871 A AU 2017219871A AU 2017219871 B2 AU2017219871 B2 AU 2017219871B2
Authority
AU
Australia
Prior art keywords
compound
hydrogen
methyl
csalkyl
optionally substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
AU2017219871A
Other languages
English (en)
Other versions
AU2017219871A1 (en
Inventor
Chih-Ming Chen
Sheng-Yung Liu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Golden Biotechnology Corp
Original Assignee
Golden Biotechnology Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Golden Biotechnology Corp filed Critical Golden Biotechnology Corp
Publication of AU2017219871A1 publication Critical patent/AU2017219871A1/en
Application granted granted Critical
Publication of AU2017219871B2 publication Critical patent/AU2017219871B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C225/00—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones
    • C07C225/20—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C225/00—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones
    • C07C225/22—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/527—Unsaturated compounds containing keto groups bound to rings other than six-membered aromatic rings
    • C07C49/543—Unsaturated compounds containing keto groups bound to rings other than six-membered aromatic rings to a six-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/527—Unsaturated compounds containing keto groups bound to rings other than six-membered aromatic rings
    • C07C49/557—Unsaturated compounds containing keto groups bound to rings other than six-membered aromatic rings having unsaturation outside the rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • C07D209/16—Tryptamines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36—Radicals substituted by singly-bound nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
    • C07D333/20—Radicals substituted by singly bound hetero atoms other than halogen by nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/16—Systems containing only non-condensed rings with a six-membered ring the ring being unsaturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Indole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AU2017219871A 2016-02-17 2017-02-16 Compositions and methods for treating liver cancer Active AU2017219871B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662296097P 2016-02-17 2016-02-17
US62/296,097 2016-02-17
PCT/US2017/018236 WO2017143106A1 (en) 2016-02-17 2017-02-16 Compositions and methods for treating liver cancer

Publications (2)

Publication Number Publication Date
AU2017219871A1 AU2017219871A1 (en) 2018-08-16
AU2017219871B2 true AU2017219871B2 (en) 2020-09-03

Family

ID=59625477

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2017219871A Active AU2017219871B2 (en) 2016-02-17 2017-02-16 Compositions and methods for treating liver cancer

Country Status (9)

Country Link
US (1) US10858307B2 (OSRAM)
EP (1) EP3416630B1 (OSRAM)
JP (1) JP6932342B2 (OSRAM)
KR (1) KR102399856B1 (OSRAM)
CN (1) CN109069448B (OSRAM)
AU (1) AU2017219871B2 (OSRAM)
ES (1) ES2961932T3 (OSRAM)
TW (1) TWI737683B (OSRAM)
WO (1) WO2017143106A1 (OSRAM)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW202532056A (zh) * 2024-01-31 2025-08-16 國鼎生物科技股份有限公司 用於治療肝癌的治療組合物

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014130619A2 (en) * 2013-02-20 2014-08-28 Golden Biotechnology Corporation Methods and compositions for treating leukemia

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI394573B (zh) * 2007-06-14 2013-05-01 國鼎生物科技股份有限公司 Application of Cynanchum auranthone Cyclohexenone Compounds in the Preparation of Drugs for Liver Protection
CN101417934B (zh) * 2007-10-24 2012-04-18 国鼎生物科技股份有限公司 分离自牛樟芝萃取物的化合物
FR2987264A1 (fr) * 2012-02-23 2013-08-30 Golden Biotechnology Corp Methodes et compositions pour le traitement des metastases cancereuses
TWI612026B (zh) * 2013-02-20 2018-01-21 國鼎生物科技股份有限公司 環己烯酮組成物及其製造方法

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014130619A2 (en) * 2013-02-20 2014-08-28 Golden Biotechnology Corporation Methods and compositions for treating leukemia

Also Published As

Publication number Publication date
WO2017143106A1 (en) 2017-08-24
TWI737683B (zh) 2021-09-01
JP2019507133A (ja) 2019-03-14
CN109069448B (zh) 2021-09-21
US20190112258A1 (en) 2019-04-18
JP6932342B2 (ja) 2021-09-08
CA3014057A1 (en) 2017-08-24
AU2017219871A1 (en) 2018-08-16
EP3416630B1 (en) 2023-10-25
EP3416630C0 (en) 2023-10-25
EP3416630A4 (en) 2019-10-09
EP3416630A1 (en) 2018-12-26
US10858307B2 (en) 2020-12-08
KR20180118634A (ko) 2018-10-31
CN109069448A (zh) 2018-12-21
ES2961932T3 (es) 2024-03-14
KR102399856B1 (ko) 2022-05-20
TW201733976A (zh) 2017-10-01

Similar Documents

Publication Publication Date Title
CA2990696C (en) (r)- and (s)-1-(3-(3-n,n-dimethylaminocarbonyl)phenoxyl-4-nitrophenyl)-1-ethyl-n,n'-bis (ethylene)phosphoramidate, compositions and methods for their use and preparation
ES2899694T3 (es) Compuestos novedosos, su síntesis y sus usos
ES2898704T3 (es) Compuestos de platino funcionalizados con monomaleimida para la terapia del cáncer
CN109152752A (zh) 一种金刚烷胺类化合物及其制备方法和用途
KR20240004584A (ko) 탈유비퀴티나아제-표적화 키메라 및 관련된 방법
Sidoryk et al. An efficient synthesis of indolo [2, 3-b] quinoline guanidine derivatives with their in vitro and in vivo study
EP3950677A1 (en) Quinolyl-containing compound and pharmaceutical composition, and use thereof
AU2017219871B2 (en) Compositions and methods for treating liver cancer
WO2022085523A1 (ja) 複合体およびその利用
CN121127267A (zh) 具有改进性质的四嗪
EP4245305A2 (en) Manufacture of trans-[tetrachlorobis(1h-indazole)ruthenate (iii)]and compositions thereof
AU2019216757B2 (en) Mebendazole prodrugs with enhanced solubility and oral bioavailability
CA2630666A1 (en) Jasmonate derivatives, pharmaceutical compositions and methods of use thereof
US20230040251A1 (en) Benzimidazole derivative having fluorine-containing substituent, preparation and application thereof
US20230416196A1 (en) Dimer of biguanidines and their therapeutic uses
US8168648B2 (en) Camptothecin derivatives and uses thereof
CN112851647A (zh) 布雷菲德菌素a衍生物及其制备方法和用途
US8877734B2 (en) Seleny-methyluracil compounds, radiosensitizer and pharmaceutical composition using them
CA3014057C (en) Compositions and methods for treating liver cancer
CA3115103A1 (en) Pi3k inhibitors and uses thereof
HK40000360A (en) Compositions and methods for treating liver cancer
US20220251124A1 (en) 3,5-bis(phenyl)-1h-heteroaryl derivatives as medicaments
KR20250168470A (ko) 캄프토테신 유도체의 항체-약물 접합체 및 이의 용도
WO2024124297A1 (en) Anti-cancer compounds and uses thereof

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)